Display options
Cite
Palumbo P, Palumbo O, Leone MP, et al. Clinical and molecular characterization of a de novo 19p13.3 microdeletion. Mol Cytogenet. 2016;9:40doi: 10.1186/s13039-016-0252-x.
Palumbo, P., Palumbo, O., Leone, M. P., Stallone, R., Palladino, T., Zelante, L., & Carella, M. (2016). Clinical and molecular characterization of a de novo 19p13.3 microdeletion. Molecular cytogenetics, 940. https://doi.org/10.1186/s13039-016-0252-x
Palumbo, Pietro, et al. "Clinical and molecular characterization of a de novo 19p13.3 microdeletion." Molecular cytogenetics vol. 9 (2016): 40. doi: https://doi.org/10.1186/s13039-016-0252-x
Palumbo P, Palumbo O, Leone MP, Stallone R, Palladino T, Zelante L, Carella M. Clinical and molecular characterization of a de novo 19p13.3 microdeletion. Mol Cytogenet. 2016 May 27;9:40. doi: 10.1186/s13039-016-0252-x. eCollection 2016. PMID: 27239227; PMCID: PMC4882821.
Copy Download .nbib Format: NLM
Share it on

Mol Cytogenet. 2016 May 27;9:40. doi: 10.1186/s13039-016-0252-x. eCollection 2016.

Clinical and molecular characterization of a de novo 19p13.3 microdeletion.

Molecular cytogenetics

Pietro Palumbo, Orazio Palumbo, Maria Pia Leone, Raffaella Stallone, Teresa Palladino, Leopoldo Zelante, Massimo Carella

Affiliations

  1. Laboratorio di Genetica Medica, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy.
  2. Laboratorio di Genetica Medica, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy ; Dipartimento di Scienze del suolo, della pianta e degli alimenti, Università degli Studi di Bari "Aldo Moro", Bari, Italy.

PMID: 27239227 PMCID: PMC4882821 DOI: 10.1186/s13039-016-0252-x

Abstract

BACKGROUND: Structural rearrangements of chromosome 19p13.3 are a rare condition, and their phenotypic consequences remain not well defined, because of the variability of clinical manifestations. Increasing knowledge of new 19p13.3 microdeletion is useful to clarify the phenotypic variability observed in some patients. In a small number of recent papers, patients with intellectual disabilities, multiple congenital anomalies and microdeletion of the chromosome band 19p13.3 have been described. However, little is known about genes responsible for clinical features in patients carriers of 19p13.3 microdeletion; thus, increasing number of reported cases will be helpful to investigate the contribution of candidate genes, providing bases for future investigations.

CASE PRESENTATION: Here, we report on a 10-years-old girl referred to our genetics clinic due to intellectual disability, attention deficit, behavioral and speech delay, hypotonia, facial dysmorphisms, eye anomalies and congenital malformations. Using an high resolution SNP array, we identified a de novo microdeletion of chromosome 19p13.3, resulting in the heterozygous loss of 27 RefSeq genes and a miRNA, partially overlapping with three others deletions already reported in literature, but extending downstream (centromeric) for additional 386 Kb. This chromosomal region includes 13 genes amongst of which we suggest for the first time the APC2, PLK5 and MBD3 genes as potential functional candidates for neurodevelopmental and behavioral phenotypes observed.

CONCLUSIONS: Here we describe a patient with a 19p13.3 microdeletion that spans to the downstream chromosomal region with respect to the overlapping deletions previously reported in several other cases. The neurobehavioral features observed in our case has extended the phenotypic spectrum associated with the 19p13.3 microdeletion. New candidate genes are proposed for the neurobehavioral phenotype observed in our case.

Keywords: 19p13.3 microdeletion; Intellectual disabilities; SNP-Array analysis

References

  1. Nat Rev Mol Cell Biol. 2009 Apr;10(4):265-75 - PubMed
  2. Am J Gastroenterol. 2000 Mar;95(3):596-604 - PubMed
  3. Biochem Biophys Res Commun. 1998 Nov 18;252(2):378-82 - PubMed
  4. Am J Med Genet A. 2015 Feb;167A(2):389-93 - PubMed
  5. Gene. 2000 Aug 22;254(1-2):45-55 - PubMed
  6. Am J Med Genet A. 2005 Jul 1;136(1):38-44 - PubMed
  7. Mol Cell Biol. 2011 Mar;31(6):1225-39 - PubMed
  8. Am J Med Genet A. 2013 Dec;161A(12):2953-63 - PubMed
  9. Cell Rep. 2015 Mar 3;:null - PubMed
  10. Genet Mol Biol. 2011 Oct;34(4):557-61 - PubMed
  11. Nature. 2004 Apr 1;428(6982):529-35 - PubMed
  12. Int J Mol Sci. 2015 Jan 07;16(1):1312-35 - PubMed
  13. J Neurosci. 2012 May 9;32(19):6468-84 - PubMed
  14. Cancer Res. 1998 Nov 15;58(22):5176-81 - PubMed
  15. Dig Liver Dis. 2013 Jul;45(7):606-11 - PubMed
  16. J Neurosci. 2009 Sep 16;29(37):11628-40 - PubMed
  17. EMBO Mol Med. 2014 Jul 07;6(8):1003-15 - PubMed
  18. Chin Med J (Engl). 2014;127(19):3438-42 - PubMed

Publication Types